The reports from the Grattan et al. found that SLC39A6 expression is positively associated with metastasis to regional lymph nodes [13], whereas Kasper et al. reported that SLC39A6 expression is associated with a positive outcome in breast cancer patients [19]. This evidence concerns the gene SLC39A6 and breast carcinoma.